Research and development continue to focus on enhancing the efficacy and safety of ICS. New formulations and delivery mechanisms are being explored to minimize side effects and improve patient adherence. Epidemiological studies will be essential in evaluating the long-term impacts of these new therapies and in identifying populations that may benefit the most.
